KCNK5 Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNK5 Gene</th>
</tr>
<tr>
<td class="label">Gene symbol</td>
<td>KCNK5</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>TASK-2 / K2P5.1</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>3779</td>
</tr>
<tr>
<td class="label">Canonical UniProt entry</td>
<td>O95279</td>
</tr>
<tr>
<td class="label">Functional class</td>
<td>Two-pore-domain background potassium channel</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a>, <a href="/wiki/migraine" style="color:#ef9a9a">Migraine</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">19 edges</a></td>
</tr>
</table>
KCNK5 encodes TASK-2 (K2P5.1), a pH-sensitive two-pore-domain potassium (K2P) channel that contributes to background/leak potassium currents and membrane potential stabilization.[@enyedi2010][@goldstein2005] K2P channels provide tonic conductance that shapes firing threshold, resting potential, and response to metabolic or inflammatory stress. In neurodegeneration research, these properties are directly relevant to selective vulnerability because chronic shifts in leak conductance can alter calcium loading, synaptic noise, and energy demand.[@busche2016][@surmeier2017]
KCNK5 is better established in epithelial and renal physiology than in classic neurodegenerative genetics; however, the TASK-channel axis is increasingly important for understanding how acid-base changes, neuroinflammatory microenvironments, and mitochondrial stress alter neuronal behavior over time.[@enyedi2010][@goldstein2005][@heneka2014]
Gene And Protein Context
TASK-2 channels respond to extracellular pH and contribute to setting electrochemical baseline conditions.[@enyedi2010][@goldstein2005] Because neurodegenerative tissue often shows altered metabolic and inflammatory states, pH-sensitive conductances are biologically plausible modifiers of disease trajectory.[@busche2016][@heneka2014]
Mechanistic Relevance To Neurodegeneration
1. pH-Dependent Excitability Tuning
Acid-base microshifts influence K2P channel gating. Through TASK-2-like mechanisms, extracellular alkalinization or acidification can move neuronal populations toward hypo- or hyperexcitability depending on cell context.[@enyedi2010][@goldstein2005] Persistent excitability imbalance is a recognized contributor to progressive synaptic injury and circuit failure in AD/PD/ALS spectra.[@busche2016][@surmeier2017]
2. Energy Stress Interface
Leak potassium conductances influence baseline membrane work and ATP demand. Under mitochondrial compromise, maladaptive leak-channel behavior can worsen energetic mismatch and increase vulnerability to oxidative injury.[@surmeier2017][@swerdlow2018] This links KCNK5 biology to broader mechanisms such as [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) and [oxidative stress](/mechanisms/oxidative-stress).
3. Inflammation-Excitability Coupling
Neuroinflammatory milieus modify extracellular ions, pH, and cytokine tone. K2P channels are therefore positioned to translate inflammatory context into electrophysiologic state changes that affect network resilience.[@busche2016][@heneka2014]
Evidence Profile
Direct evidence assigning KCNK5 as a monogenic cause of AD/PD/ALS is currently limited. The practical evidence tier is:
- strong mechanistic plausibility from K2P physiology and excitability biology,
- supportive systems evidence from studies of network instability in neurodegeneration,
- limited direct disease-genetics evidence specific to KCNK5 in common neurodegenerative disorders.[@enyedi2010][@busche2016][@surmeier2017]
This places KCNK5 in a high-value hypothesis space for modifier modeling and biomarker-stratified experiments.
Translational Implications
Include KCNK5/TASK-channel expression in electrophysiology-first subgrouping of patient-derived neuronal models.
Test whether modulating pH-sensitive leak conductances reduces stress phenotypes when combined with mitochondrial support interventions.
Track leak-channel signatures alongside fluid biomarkers and digital motor/cognitive metrics in longitudinal cohorts.[@busche2016][@surmeier2017][@swerdlow2018]No KCNK5-targeted disease-modifying therapy is established; translational work is currently preclinical-to-early-discovery.
Research Priorities
- Map KCNK5 expression across human brain regions and disease stages.
- Define interaction between TASK-2 signaling and inflammatory cytokine environments in glia-neuron co-culture systems.
- Quantify whether KCNK5 perturbation changes progression phenotypes in human iPSC neuron models with AD/PD/ALS risk backgrounds.
See Also
- [Ion channel dysfunction](/mechanisms/ion-channel-dysfunction)mechanisms/ion-channel-dysfunction-neurodegeneration)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Oxidative stress](/mechanisms/oxidative-stress)
- [Autophagy-lysosome dysfunction](/mechanisms/autophagy-lysosome-dysfunction)
External Links
- [NCBI Gene: KCNK5](https://www.ncbi.nlm.nih.gov/gene/3779)
- [UniProt: KCNK5 (TASK-2)](https://www.uniprot.org/uniprotkb/O95279/entry)
References
[Enyedi P, Czirjak G, Molecular background of leak K+ currents: two-pore domain potassium channels (2010)](https://pubmed.ncbi.nlm.nih.gov/20625170/)
[Goldstein SAN, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S, International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels (2005)](https://pubmed.ncbi.nlm.nih.gov/16099889/)
[Busche MA, Konnerth A, Impairments of neural circuit function in Alzheimer's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27891207/)
[Surmeier DJ, Obeso JA, Halliday GM, Selective neuronal vulnerability in Parkinson disease (2017)](https://pubmed.ncbi.nlm.nih.gov/25442937/)
[Heneka MT, Kummer MP, Latz E, Innate immune activation in neurodegenerative disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25287947/)
[Swerdlow RH, Mitochondria and mitochondrial cascades in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/28190533/)